^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

nab-paclitaxel/rituximab nanoparticle (AR160)

i
Other names: AR160
Company:
Mayo Clinic, Sorrento
Drug class:
Bcl2 inhibitor, CD20 inhibitor, Tubulin inhibitor
Related drugs: